JP2001508761A - 皮膚コンディションの改善方法 - Google Patents
皮膚コンディションの改善方法Info
- Publication number
- JP2001508761A JP2001508761A JP54246197A JP54246197A JP2001508761A JP 2001508761 A JP2001508761 A JP 2001508761A JP 54246197 A JP54246197 A JP 54246197A JP 54246197 A JP54246197 A JP 54246197A JP 2001508761 A JP2001508761 A JP 2001508761A
- Authority
- JP
- Japan
- Prior art keywords
- support layer
- skin
- wekroma
- magnetic vector
- potential field
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims abstract description 38
- 102000008186 Collagen Human genes 0.000 claims description 35
- 108010035532 Collagen Proteins 0.000 claims description 35
- 229920001436 collagen Polymers 0.000 claims description 35
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 27
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 14
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 12
- 239000011780 sodium chloride Substances 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 7
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 6
- 239000004973 liquid crystal related substance Substances 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 239000007789 gas Substances 0.000 claims description 3
- 230000006872 improvement Effects 0.000 claims description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 3
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 2
- 229910001424 calcium ion Inorganic materials 0.000 claims description 2
- 229910052742 iron Inorganic materials 0.000 claims description 2
- -1 iron ions Chemical class 0.000 claims description 2
- 239000007791 liquid phase Substances 0.000 claims 6
- 239000012071 phase Substances 0.000 claims 2
- 239000000243 solution Substances 0.000 description 23
- 229910052500 inorganic mineral Inorganic materials 0.000 description 20
- 239000011707 mineral Substances 0.000 description 20
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 19
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 19
- 210000003491 skin Anatomy 0.000 description 16
- 102000004169 proteins and genes Human genes 0.000 description 13
- 108090000623 proteins and genes Proteins 0.000 description 13
- 239000012266 salt solution Substances 0.000 description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 239000000523 sample Substances 0.000 description 12
- 238000012360 testing method Methods 0.000 description 10
- 238000011282 treatment Methods 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 9
- 210000002950 fibroblast Anatomy 0.000 description 8
- 230000037319 collagen production Effects 0.000 description 7
- 230000001632 homeopathic effect Effects 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 230000002500 effect on skin Effects 0.000 description 5
- 238000012423 maintenance Methods 0.000 description 5
- 239000002953 phosphate buffered saline Substances 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 102000016942 Elastin Human genes 0.000 description 4
- 108010014258 Elastin Proteins 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 229920002549 elastin Polymers 0.000 description 4
- 238000010348 incorporation Methods 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 239000012488 sample solution Substances 0.000 description 4
- 238000003556 assay Methods 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 210000004207 dermis Anatomy 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 102000012422 Collagen Type I Human genes 0.000 description 2
- 108010022452 Collagen Type I Proteins 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- 240000001140 Mimosa pudica Species 0.000 description 2
- 235000016462 Mimosa pudica Nutrition 0.000 description 2
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 2
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- ZLCOWUKVVFVVKA-WDSKDSINSA-N (2r)-3-[[(2r)-2-acetamido-2-carboxyethyl]disulfanyl]-2-aminopropanoic acid Chemical compound CC(=O)N[C@H](C(O)=O)CSSC[C@H](N)C(O)=O ZLCOWUKVVFVVKA-WDSKDSINSA-N 0.000 description 1
- XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 235000011468 Albizia julibrissin Nutrition 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 208000035484 Cellulite Diseases 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000001126 Keratosis Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 241001070944 Mimosa Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010049752 Peau d'orange Diseases 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 206010064127 Solar lentigo Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 230000036232 cellulite Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 206010021198 ichthyosis Diseases 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000037312 oily skin Effects 0.000 description 1
- 238000003359 percent control normalization Methods 0.000 description 1
- INAAIJLSXJJHOZ-UHFFFAOYSA-N pibenzimol Chemical compound C1CN(C)CCN1C1=CC=C(N=C(N2)C=3C=C4NC(=NC4=CC=3)C=3C=CC(O)=CC=3)C2=C1 INAAIJLSXJJHOZ-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/83—Electrophoresis; Electrodes; Electrolytic phenomena
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/87—Application Devices; Containers; Packaging
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Radiology & Medical Imaging (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Birds (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Apparatuses For Bulk Treatment Of Fruits And Vegetables And Apparatuses For Preparing Feeds (AREA)
- Fats And Perfumes (AREA)
- Lasers (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/646,798 US5905265A (en) | 1996-05-21 | 1996-05-21 | Method of improving skin condition |
| US08/646,798 | 1996-05-21 | ||
| PCT/US1997/007936 WO1997044810A1 (en) | 1996-05-21 | 1997-05-13 | Method of improving skin condition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2001508761A true JP2001508761A (ja) | 2001-07-03 |
Family
ID=24594498
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP54246197A Pending JP2001508761A (ja) | 1996-05-21 | 1997-05-13 | 皮膚コンディションの改善方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5905265A (enExample) |
| JP (1) | JP2001508761A (enExample) |
| KR (1) | KR100450713B1 (enExample) |
| CN (1) | CN1123050C (enExample) |
| AR (1) | AR048562A1 (enExample) |
| AU (1) | AU708049B2 (enExample) |
| CA (1) | CA2256348C (enExample) |
| CO (1) | CO4850561A1 (enExample) |
| IL (1) | IL127182A0 (enExample) |
| IN (1) | IN183686B (enExample) |
| TW (2) | TWI272635B (enExample) |
| WO (1) | WO1997044810A1 (enExample) |
| ZA (1) | ZA974421B (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003137807A (ja) * | 2001-11-01 | 2003-05-14 | Miyagi Kagaku Kogyo Kk | コラーゲン産生促進剤、それを含む化粧品、食品および医薬品ならびに皮膚疾患の予防または改善用外用剤 |
| JP2007039397A (ja) * | 2005-08-04 | 2007-02-15 | Sapporo Breweries Ltd | ビール酵母で発酵させたアルコール飲料からコラーゲン産生促進作用を有する組成物を製造する方法及びその組成物 |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2177306T3 (es) | 1998-07-27 | 2002-12-01 | John Nikolaj Hvarre | Dispositivo y procedimiento para el tratamiento del agua para uso domestico y del agua potable. |
| US6290993B1 (en) * | 1999-07-23 | 2001-09-18 | E-L Management Corp. | Compositions containing mimosa phenolic compounds |
| DE10223221A1 (de) * | 2002-05-24 | 2003-12-11 | Sebapharma Gmbh & Co Kg | Kosmetische Zusammensetzung mit hautentquellender Wirkung |
| JP2004167467A (ja) * | 2002-11-15 | 2004-06-17 | Lidic Inc | 振動情報記録水 |
| GR1004816B (el) * | 2003-05-07 | 2005-02-18 | Evalion Ανωνυμη Εταιρεια Παροχης Υπηρεσιων-Συμβουλευτικη-Εμπορικη | Μεθοδος μεταφορας συχνοτητων σε ουσιες μεσω κρυσταλλων και παρασκευη σκευασματων τα οποια περιεχουν τις συχνοτητες αυτες |
| JP2004337831A (ja) * | 2003-05-16 | 2004-12-02 | Lidic Inc | 生体の生命力を支援する振動情報の生成方法 |
| US20100181261A1 (en) * | 2009-01-22 | 2010-07-22 | Eagle Research LLC | Aqueous environment treatment apparatus and method |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3612315A1 (de) * | 1986-04-11 | 1987-10-22 | Kropp Werner | Substrat und verfahren sowie vorrichtung zu seiner herstellung |
| AU8219491A (en) * | 1990-07-06 | 1992-02-04 | Iit Research Institute | Method and apparatus for rendering medical materials safe |
| US5247179A (en) * | 1990-10-18 | 1993-09-21 | Hiroshi Tachibana | Activation energy providing device |
-
1996
- 1996-05-21 US US08/646,798 patent/US5905265A/en not_active Expired - Fee Related
-
1997
- 1997-05-13 IL IL12718297A patent/IL127182A0/xx unknown
- 1997-05-13 AU AU30028/97A patent/AU708049B2/en not_active Ceased
- 1997-05-13 KR KR10-1998-0709302A patent/KR100450713B1/ko not_active Expired - Fee Related
- 1997-05-13 CN CN97196632A patent/CN1123050C/zh not_active Expired - Fee Related
- 1997-05-13 WO PCT/US1997/007936 patent/WO1997044810A1/en not_active Ceased
- 1997-05-13 JP JP54246197A patent/JP2001508761A/ja active Pending
- 1997-05-13 CA CA002256348A patent/CA2256348C/en not_active Expired - Fee Related
- 1997-05-20 AR ARP970102131A patent/AR048562A1/es unknown
- 1997-05-21 TW TW090102193A patent/TWI272635B/zh not_active IP Right Cessation
- 1997-05-21 CO CO97027714A patent/CO4850561A1/es unknown
- 1997-05-21 ZA ZA9704421A patent/ZA974421B/xx unknown
- 1997-05-21 TW TW086106812A patent/TW483020B/zh not_active IP Right Cessation
- 1997-05-21 IN IN1083MA1997 patent/IN183686B/en unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003137807A (ja) * | 2001-11-01 | 2003-05-14 | Miyagi Kagaku Kogyo Kk | コラーゲン産生促進剤、それを含む化粧品、食品および医薬品ならびに皮膚疾患の予防または改善用外用剤 |
| JP2007039397A (ja) * | 2005-08-04 | 2007-02-15 | Sapporo Breweries Ltd | ビール酵母で発酵させたアルコール飲料からコラーゲン産生促進作用を有する組成物を製造する方法及びその組成物 |
Also Published As
| Publication number | Publication date |
|---|---|
| AU708049B2 (en) | 1999-07-29 |
| TW483020B (en) | 2002-04-11 |
| WO1997044810A1 (en) | 1997-11-27 |
| CA2256348A1 (en) | 1997-11-27 |
| TWI272635B (en) | 2007-02-01 |
| IN183686B (enExample) | 2000-03-18 |
| IL127182A0 (en) | 1999-09-22 |
| CN1123050C (zh) | 2003-10-01 |
| AU3002897A (en) | 1997-12-09 |
| CO4850561A1 (es) | 1999-10-26 |
| CN1226338A (zh) | 1999-08-18 |
| KR20000011142A (ko) | 2000-02-25 |
| ZA974421B (en) | 1997-12-22 |
| KR100450713B1 (ko) | 2004-12-03 |
| CA2256348C (en) | 2002-07-23 |
| AR048562A1 (es) | 2006-05-10 |
| US5905265A (en) | 1999-05-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gabbiani et al. | Human smooth muscle autoantibody: its identification as antiactin antibody and a study of its binding to “nonmuscular” cells | |
| Freitas et al. | The effect of Phyllanthus niruri on urinary inhibitors of calcium oxalate crystallization and other factors associated with renal stone formation | |
| Siméon et al. | Expression and activation of matrix metalloproteinases in wounds: modulation by the tripeptide–copper complex glycyl-L-histidyl-L-lysine-Cu2+ | |
| Gamble et al. | Regulation of human monocyte adherence by granulocyte-macrophage colony-stimulating factor. | |
| JP2002502413A (ja) | 創傷治療のための部材及び方法 | |
| JPH0441413A (ja) | 毛髪改質剤 | |
| JP2001508761A (ja) | 皮膚コンディションの改善方法 | |
| JPH0661262B2 (ja) | 細胞増殖の刺激方法 | |
| WO2023082218A1 (zh) | 纳米硒海藻酸钠复合凝胶及制备方法和应用 | |
| Philpott et al. | Improved selective cytotoxicity with an antibody-diphtheria toxin conjugate | |
| Shimojo et al. | Identification and characterization of a tissue kallikrein in rat skeletal muscles | |
| MD1521F2 (en) | Methods of thrombus forming inhibition, methods of treatment of thrombotic states, pharmaceutical compositions and kit for treatment of thrombotic states | |
| Muzykantov et al. | Target-sensitive immunoerythrocytes: interaction of biotinylated red blood cells with immobilized avidin induces their lysis by complement | |
| JP2008247779A (ja) | 抗アレルギー食品及び抗アレルギー外用剤 | |
| JPH06508111A (ja) | 甲状腺由来の軟骨細胞刺激因子 | |
| CN102379917A (zh) | 应用豆类产品治疗和预防放疗引起的皮肤损伤 | |
| Storm et al. | Natural thermal resistance of human tumor cells and the role of prostaglandin | |
| CA1052696A (en) | Preparations for treatment of acne vulgaris | |
| CN119280077B (zh) | 一种完全负载棕榈酰蓝铜肽的微球制备和应用 | |
| KR102497294B1 (ko) | 신규 펩타이드를 유효성분으로 포함하는 피부 질환 예방 및 개선용 피부 외용제 조성물 | |
| HK40078679B (zh) | 包含源自山茶籽油粕的类黄酮糖苷的用於恢复皮肤屏障功能的组合物 | |
| Tseng et al. | Through Modulation of the M2 Macrophage Subpopulation | |
| CN116262098A (zh) | 一种皮肤抗衰修复组合物及包含其的多层脂质纳米粒 | |
| KR20000024460A (ko) | 복합항원체를 이용한 계란복합항체의 생산 및 피부질환치료용 조성물 | |
| Phecolax | the principal ingredients. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050614 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20050908 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20051024 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20051214 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20070320 |
|
| A72 | Notification of change in name of applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A721 Effective date: 20070615 |